Intelligence · Patents

Patents expiring in 2029

Annual patent cliff calendar for 2029 — US pharmaceutical patents by expiration date.

Patents
675

Quick answer

675 indexed pharmaceutical patents have expiration dates in 2029. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7629005

    Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

    Bionorica AG · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7629336

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7629380

    Antitumor agents

    The Regents of the University of California · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7632503

    Method of treating a muscle-related condition with modified IGF1 polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7632490

    Use of IL-1 antagonists to treat gout

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7632502

    Cell wall mannoproteins and active epitopes from Candida albicans and antibodies recognizing them

    The Board of Regents of the University of Texas System · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7632841

    2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7632484

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7632814

    HYD1 peptides as anti-cancer agents

    The Regents of the University of California · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7632510

    Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7632659

    Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

    The United States of America as represented by the Secretary of the Army · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7632932

    Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7632847

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7632508

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

    The United States of America · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7635712

    Salinosporamides and methods for use thereof

    The Regents of the University of California · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7635485

    Method of accelerated vaccination against Ebola viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7635486

    Recombinant lipidated PsaA protein, methods of preparation and use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7635483

    Streptococcal C5a peptidase vaccine

    Regents of the University of Minnesota · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7635476

    Anti-hepatitis a virus antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7635474

    VEGF-binding fusion proteins

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7635683

    Quinoxalinyl tripeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7635688

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7638678

    Animal model for perimenopause and menopause and methods of inducing ovarian failure

    THE ARIZONA BOARD OF REGENTS · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7638507

    Compositions for treatment of inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7638501

    Method of treatment of mitochondrial disorders

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7638544

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7638494

    G-type peptides to ameliorate atherosclerosis

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7638284

    Immunoglobulin A inducing protein and uses therefor

    The Board of Regents of the University of Texas · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7638269

    Viral capsid assembly intermediates and methods of production

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7638300

    In vivo incorporation of unnatural amino acids

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7638283

    Amyloid β protein (globular assembly and uses thereof)

    Northwestern University · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7638135

    Collagen-binding proteins from enterococcal bacteria

    The Board of Regents of the University of Texas System · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7638145

    Cultivated agarwood

    Regents of the University of Minnesota · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7638130

    Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7638550

    Pyrrolic derivatives with histone deacetylase inhibitory activity

    Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU) Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III (CNIO) · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7638282

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7638134

    Insertion sites in fowlpox vectors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7638333

    Anthrax vaccine

    The United States of America as represented by the Secretary of the Army · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7638638

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7638640

    Purifications of pomegranate ellagitannins and their uses thereof

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7638639

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7638624

    Compositions and methods relating to novel benzodiazepine compounds and derivatives

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7638543

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7641902

    Compositions and methods for detecting cancer and for inhibiting metastasis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7641906

    Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7642275

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7642234

    Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7642355

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2029?

675 published patents in our USPTO index have expiration dates falling in calendar year 2029.